Effect of Vimentin Protein in Female Iraqi bariatric surgery patients with diabetes mellitus

Obesity has come to be a serious global health risk that can cause a number of chronic, frequently fatal diseases, such as type 2 diabetes and coronary artery disease. Conventional weight-loss approaches such as diet, exercise, and medication typically have relatively poor long-term results. Bariatric surgery is the greatest option for treating patients who are morbidly obese because it allows for substantial, long-term weight loss and improves or resolves obesity-related comorbidities, all of which reduce mortality rates. Vimentin indicate is assessed utilizing thorough cross-sectional research and some biochemical markers. Ninety female blood samples total, divided into three groups, were used in the study. Before BS, group A had type 2 diabetes mellitus (DM) due to obesity; group B was the same group A, however after BS; and group C was the control group. The findings showed that, in comparison to the control group, the patient D.M.'s HbA1c and BMI values increased significantly (P≤0.05) before and after the BS groups. The results also showed that, in all patient groups, the concentrations of urea, creatinine, and uric acid increased significantly. All patient groups showed a considerable rise in vimentin concentration as compared to the control group. This present study led us to the conclusion that vimentin had a noticeable impact on biochemical markers in obese people with pre-diabetes.rese